136 related articles for article (PubMed ID: 37142000)
1. In vitro validation of an in vivo phenotyping drug cocktail for major drug transporters in humans.
Hsin CH; Kuehne A; Gu Y; Jedlitschky G; Hagos Y; Gründemann D; Fuhr U
Eur J Pharm Sci; 2023 Jul; 186():106459. PubMed ID: 37142000
[TBL] [Abstract][Full Text] [Related]
2. Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation.
Yin J; Duan H; Wang J
J Pharmacol Exp Ther; 2016 Dec; 359(3):401-410. PubMed ID: 27758931
[TBL] [Abstract][Full Text] [Related]
3. The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail.
Ebner T; Ishiguro N; Taub ME
J Pharm Sci; 2015 Sep; 104(9):3220-8. PubMed ID: 25981193
[TBL] [Abstract][Full Text] [Related]
4. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney.
Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y
J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731
[TBL] [Abstract][Full Text] [Related]
5. Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K.
Yin J; Wagner DJ; Prasad B; Isoherranen N; Thummel KE; Wang J
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F805-F814. PubMed ID: 31322418
[TBL] [Abstract][Full Text] [Related]
6. Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1.
Sato T; Masuda S; Yonezawa A; Tanihara Y; Katsura T; Inui K
Biochem Pharmacol; 2008 Oct; 76(7):894-903. PubMed ID: 18674516
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of sixteen pharmaceutical excipients on six major organic cation and anion uptake transporters.
Ma R; Li G; Wang X; Bi Y; Zhang Y
Xenobiotica; 2021 Jan; 51(1):95-104. PubMed ID: 32544367
[TBL] [Abstract][Full Text] [Related]
8. A Clinical Drug-Drug Interaction Study Assessing a Novel Drug Transporter Phenotyping Cocktail With Adefovir, Sitagliptin, Metformin, Pitavastatin, and Digoxin.
Trueck C; Hsin CH; Scherf-Clavel O; Schaeffeler E; Lenssen R; Gazzaz M; Gersie M; Taubert M; Quasdorff M; Schwab M; Kinzig M; Sörgel F; Stoffel MS; Fuhr U
Clin Pharmacol Ther; 2019 Dec; 106(6):1398-1407. PubMed ID: 31247117
[TBL] [Abstract][Full Text] [Related]
9. Characterization of
López Quiñones AJ; Wagner DJ; Wang J
Mol Pharmacol; 2020 Aug; 98(2):109-119. PubMed ID: 32487736
[TBL] [Abstract][Full Text] [Related]
10. Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells.
Tsuda M; Terada T; Ueba M; Sato T; Masuda S; Katsura T; Inui K
J Pharmacol Exp Ther; 2009 Apr; 329(1):185-91. PubMed ID: 19164462
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Renal Efflux Transporter MATE1 in Renal Excretion of Flecainide.
Doki K; Apáti S; Sakata T; Homma M
Biol Pharm Bull; 2019; 42(7):1226-1229. PubMed ID: 31257298
[TBL] [Abstract][Full Text] [Related]
12. Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein.
Chu XY; Bleasby K; Yabut J; Cai X; Chan GH; Hafey MJ; Xu S; Bergman AJ; Braun MP; Dean DC; Evers R
J Pharmacol Exp Ther; 2007 May; 321(2):673-83. PubMed ID: 17314201
[TBL] [Abstract][Full Text] [Related]
13. The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2.
Jouan E; Le Vee M; Denizot C; Da Violante G; Fardel O
Fundam Clin Pharmacol; 2014 Feb; 28(1):65-77. PubMed ID: 22913740
[TBL] [Abstract][Full Text] [Related]
14. OCT2 and MATE1 provide bidirectional agmatine transport.
Winter TN; Elmquist WF; Fairbanks CA
Mol Pharm; 2011 Feb; 8(1):133-42. PubMed ID: 21128598
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Transporters for Organic Cations by High Glucose.
Steinbüchel M; Menne J; Schröter R; Neugebauer U; Schlatter E; Ciarimboli G
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762353
[TBL] [Abstract][Full Text] [Related]
16. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.
Mandíková J; Volková M; Pávek P; Česnek M; Janeba Z; Kubíček V; Trejtnar F
Toxicology; 2013 Sep; 311(3):135-46. PubMed ID: 23856525
[TBL] [Abstract][Full Text] [Related]
17. Metformin transport by renal basolateral organic cation transporter hOCT2.
Kimura N; Okuda M; Inui K
Pharm Res; 2005 Feb; 22(2):255-9. PubMed ID: 15783073
[TBL] [Abstract][Full Text] [Related]
18. Renal Excretion of Dabigatran: The Potential Role of Multidrug and Toxin Extrusion (MATE) Proteins.
Shen H; Yao M; Sinz M; Marathe P; Rodrigues AD; Zhu M
Mol Pharm; 2019 Sep; 16(9):4065-4076. PubMed ID: 31335150
[TBL] [Abstract][Full Text] [Related]
19. Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins.
Yin J; Duan H; Shirasaka Y; Prasad B; Wang J
Drug Metab Dispos; 2015 Dec; 43(12):1872-81. PubMed ID: 26374172
[TBL] [Abstract][Full Text] [Related]
20. Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluation.
Rizk ML; Houle R; Chan GH; Hafey M; Rhee EG; Chu X
Antimicrob Agents Chemother; 2014; 58(3):1294-301. PubMed ID: 24295974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
